
‘Groundbreaking’ Gene-Editing Therapy Receives Ethical Thumbs Up
Casgevy is a new treatment for sickle cell disease, a blood disorder that affects approximately 100,000 Americans.
Casgevy is a new treatment for sickle cell disease, a blood disorder that affects approximately 100,000 Americans.
Joseph Meaney, PH.D., speaking Friday in an interview on EWTN Pro-Life Weekly, said that the experiment gone wrong was predictable, because “science, as it emerges into new areas, makes a lot of mistakes.”
Gene-editing technology promises to help solve the rarest diseases afflicting humanity — but designing human embryos is a bridge too far.
A Chinese scientist says he has helped a couple achieve a twin pregnancy.
‘Their value as human beings is profoundly denigrated every time they are created, experimented upon, and then killed,’ said priest-scientist.
Subscriber Service CenterAlready a subscriber? Renew or manage your subscription here.
Subscribe for just $49.95 $32.50!Start your Register subscription today.
Give a Gift SubscriptionBless friends, family or clergy with a gift of the Register.
Order NowOrder Bulk SubscriptionsGet a discount on 6 or more copies sent to your parish, organization or school.
Order NowSign-up for E-NewsletterGet Register Updates sent daily or weeklyto your inbox.
Sign Up